Press release
Pemphigus Vulgaris Treatment Market Projected to Augment at a Notable CAGR during the Forecast Period until 2028 | Top Key Players- F. Hoffmann-La Roche Ltd, Novartis AG, Sanofi, GlaxoSmithClaine, Syntimmune, Argenx, Principia Biopharma, and HanAll Biopha
Fact.MR
Request Full Report With TOC- https://www.factmr.com/connectus/sample?flag=T&rep_id=2185
Pemphigus Vulgaris Treatment Market: Drivers and Restraints
The increasing demand for biological therapies for pemphigus vulgaris treatment is because of their less side effects. Whereas, glucocorticoids can lead to several drug-related reactions. The growing demand for Mabs is expected to drive the growth of the pemphigus vulgaris treatment market during the forecast period. As there are less options available in market for pemphigus vulgaris treatment, and various side effects of marketed non-biological drugs, boost up the research for Pemphigus Vulgaris Treatment and its market. However, high cost of biological drugs and its availability are the major factors expected to hinder the growth of the pemphigus vulgaris treatment market.
Pemphigus Vulgaris Treatment Market: Segmentation
Tentatively, the global pemphigus vulgaris treatment market can be segmented on the basis of types of treatment, route of administration and distribution channel.
Based on Types of Treatment, the global pemphigus vulgaris treatment market is segmented as:
Non-biological treatment
Corticosteroids
Immunosuppressants (Mycophenolate mofetis, Azathioprin)
Antibiotics, antifungal or anti-viral medication
Other medications (Dapsone)
Biological therapies (Mabs or monoclonal antibodies such as, Rituximab)
Based on the Route of Administration (RoA), the global pemphigus vulgaris treatment market is segmented as:
Subcutaneous
Peroeral
Intravenous
Based on the Distribution Channel, the global pemphigus vulgaris treatment market is segmented as:
Retailers
Pharmacy
E-Commerce
To know more about the Pemphigus Vulgaris Treatment Market Trends, visit this link- https://www.factmr.com/report/2185/pemphigus-vulgaris-treatment-market
Pemphigus Vulgaris Treatment Market: Overview
The global market for pemphigus vulgaris treatment is expected to witness significant growth over the forecast period due to high demand for biological therapies for pemphigus vulgaris treatment. By RoA, the subcutaneous drug delivery segment is expected to experience high demand, as it delivers the drug directly to the blood stream resulting in less side effects. Among various indications of pemphigus vulgaris treatment, is expected to gain attraction over the forecast period, primarily due to growing prevalence of Pemphigus Vulgaris (PV). Some of the popular brands of Pemphigus Vulgaris Treatment market include MabThera (F. Hoffmann-La Roche Ltd), Prednisone (Sanofi) etc.
Pemphigus Vulgaris Treatment: Regional Outlook
Geographically, the global pemphigus vulgaris treatment market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific Excluding Japan, Japan and the Middle East & Africa. North America is expected to be the dominant regional market for pemphigus vulgaris treatment on account of growing research and development for novel pemphigus vulgaris treatment along with advancements in the healthcare sector. The Europe pemphigus vulgaris treatment market is expected to account second large revenue share in the global pemphigus vulgaris treatment market over the forecast period owing to increasing prevalence of pemphigus vulgaris in the region. Fast growth is expected in the Asia-Pacific market, due to technological advancement in the health care sector and increasing investment in life-science research.
Pemphigus Vulgaris Treatment: Key Players
The global pemphigus vulgaris treatment market is highly fragmented with a large number of global players operating. Examples of some of the key players operating in the global pemphigus vulgaris treatment market are F. Hoffmann-La Roche Ltd, Novartis AG, Sanofi, GlaxoSmithClaine, Syntimmune, Argenx, Principia Biopharma, and HanAll Biopharma, among others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Connect To An Expert- https://www.factmr.com/connectus/sample?flag=AE&rep_id=2185
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at- https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pemphigus Vulgaris Treatment Market Projected to Augment at a Notable CAGR during the Forecast Period until 2028 | Top Key Players- F. Hoffmann-La Roche Ltd, Novartis AG, Sanofi, GlaxoSmithClaine, Syntimmune, Argenx, Principia Biopharma, and HanAll Biopha here
News-ID: 1338471 • Views: …
More Releases from Fact.MR
Enriched Dough Market Projected to Reach US$ 621.1 Million by 2032, Growing at a …
By the end of 2032, the global enriched dough market is expected to have generated more than US$ 621 million in revenue, up from US$ 405.8 million at now. The consumption of enriched dough is expected to rise globally at a CAGR of 4.3% between 2022 and 2032.
The usage of enriched dough has expanded notably in the bakery business, as a result of the growing awareness of health and fitness.…
Baby Bottle Market Expected to Surpass US$ 5.8 Billion by 2034 at 4.7% CAGR
According to a Fact.MR report, the global baby bottle market is expected to develop at a compound annual growth rate (CAGR) of 4.7%, from a valuation of US$ 3.7 billion in 2024 to US$ 5.8 billion by the end of 2034.
The demand for them is expected to rise as more parents become aware of the benefits of bottle feeding infants in the early stages of life. Baby bottle sales are…
Bagless Vacuum Cleaners Market Is Predicted To Touch US$ 39.52 Billion By 2033: …
The global demand for bagless vacuum cleaners is forecasted to experience a compound annual growth rate (CAGR) of 8% from 2023 to 2033. Consequently, the market for bagless vacuum cleaners worldwide is anticipated to surge from a value of US$ 18.3 billion in 2023 to reach US$ 39.52 billion by the end of 2033.
The Bagless Vacuum Cleaner Industry sales study offers a comprehensive analysis on diverse features including production…
NFC Chips Are Predicted To Reach US$ 7.6 Billion At A CAGR Of 15% By 2033: Fact. …
The global NFC chip market is valued at US$ 1.9 billion in 2023 and is forecasted to surge at a CAGR of 15% to reach a market size of US$ 7.6 billion by the end of 2033.
The NFC Chip Industry sales study offers a comprehensive analysis on diverse features including production capacities, NFC Chip demand, product developments, sales revenue generation and NFC Chip market outlook across the globe.
market research…
More Releases for Pemphigus
Pemphigus Vulgaris Treatment is Emerging Economies with Principia Biopharma, Arg …
Global Pemphigus Vulgaris Treatment Market Report 2020 is latest research study released by CMI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Pemphigus Vulgaris Treatment Market. Some of the key players profiled in the study are Principia Biopharma, Argenx SE, Alexion…
Global Pemphigus Vulgaris Market Research Report Forecast to 2027
Pemphigus Vulgaris Market 2020 comprises a detailed survey of the Pemphigus Vulgaris Market size, share, trends, extension, consumption, and share, segments, application and Forecast 2025.
Global "Pemphigus Vulgaris" Market 2020-2025 Report contains all demographic as well as analytical data regarding market review, growth, demand, and budget analysis.
The report mainly highlights the significant trends of the Pemphigus Vulgaris market in terms of thriving companies, business methods, product values and pricing, revenue,…
Pemphigus Vulgaris Treatment Market Research 2020 by Industry Size, Trends and F …
The authors of the report have deeply researched about key areas of the global Pemphigus Vulgaris Treatment market and provided verified market findings and reliable recommendations to help players ensure long-term growth.
The report on the global Pemphigus Vulgaris Treatment market is just the resource that players need to strengthen their overall growth and establish a strong position in their business. It is a compilation of detailed, accurate research studies that…
Pemphigus Vulgaris Treatment Market Shares, Strategies and Forecast Worldwide, 2 …
Pemphigus vulgaris (PV) is a rare auto-immune disorder with less treatment options. It causes painful blisters on the mucous membrane of the eye, genitals, mouth, throat, nose or skin. Pemphigus vulgaris does not depends on age of a person, it can affect anybody. Pemphigus vulgaris mainly develops due to adverse drug reaction (ADR) of drugs such as enalapril, captopril, penicillamine, some antibiotics, etc. Based on the severity of symptoms, sometimes…
Growing Global Prevalence of Cancer and Increasing Consumption of Tobacco Drive …
Paraneoplastic pemphigus is an autoimmune disease characterized by the formation of blisters that affect the mucous membranes and / or skin. It falls under the “rare diseases” category and can affect both males and females. According to Ophanet, paraneoplastic pemphigus affects 1 in 2,000 people. It is a rare form of pemphigus usually associated with lymph proliferative disorders such as Castleman disease, chronic lymphocytic leukemia, and non-Hodgkin’s lymphoma.
Paraneoplastic…
Paraneoplastic Pemphigus (PNP) Disease Market Forecast Research Reports Offers K …
Paraneoplastic pemphigus is an autoimmune disease characterized by the formation of blisters that affect the mucous membranes and / or skin. It falls under the “rare diseases” category and can affect both males and females. According to Ophanet, paraneoplastic pemphigus affects 1 in 2,000 people. It is a rare form of pemphigus usually associated with lymph proliferative disorders such as Castleman disease, chronic lymphocytic leukemia, and non-Hodgkin’s lymphoma. Paraneoplastic…
